Register for free
Recent Quotes
My Watchlist
Indicators
Business Insurance Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Estrella Immunopharma, Inc. - Warrant (NQ:ESLAW)

0.1050 -0.0051 (-4.63%)
Streaming Delayed Price Updated: 11:10 AM EDT, May 28, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,500
Open 0.0751
Bid (Size) 0.0800 (1,500)
Ask (Size) 0.1300 (100)
Prev. Close 0.1101
Today's Range 0.0751 - 0.1050
52wk Range 0.0305 - 0.2400
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Estrella Immunopharma to Participate in the D. Boral Capital Global Conference
From Estrella Immunopharma, Inc.
Via Business Wire
News headline image
Estrella Immunopharma, Inc. (NASDAQ: ESLA) Receives Initiating Coverage with a Valuation of $12.00/Share from Zacks Small-Cap Research
From Estrella Immunopharma, Inc.
Via Business Wire

Performance

YTD
+70.5%
+70.5%
1 Month
-17.6%
-17.6%
3 Month
-9.5%
-9.5%
6 Month
+6.1%
+6.1%
1 Year
+132.3%
+132.3%

More News

Read More
News headline image
Estrella Immunopharma Presents Promising Updated Data on EB103 in Oral Presentation at the 2026 Tandem Meetings of ASTCT® & CIBMTR®
From Estrella Immunopharma, Inc.
Via Business Wire
News headline image
Estrella Immunopharma Announces Closing of $8.0 Million Registered Direct Offering and Concurrent Private Placement
From Estrella Immunopharma, Inc.
Via Business Wire
News headline image
Estrella Immunopharma Completes First Dose Cohort in STARLIGHT-1 Trial and Receives Approval to Initiate Higher Dose Cohort
From Estrella Immunopharma
Via Business Wire
News headline image
Estrella Immunopharma, Inc. (NASDAQ: ESLA; ESLAW) Receives Buy Rating with a 12-Month Price Target of $16.00 from D. Boral Capital
From Estrella Immunopharma, Inc.
Via Business Wire
News headline image
Estrella Immunopharma Achieves Complete Response in First Patient Treated with CD19- Redirected ARTEMIS® T-cells
From Estrella Immunopharma, Inc.
Via Business Wire
News headline image
Estrella Immunopharma Announces Appointment of Hong Zhang as Chairperson and Board Member
From Estrella Immunopharma, Inc.
Via Business Wire

Frequently Asked Questions

Is Estrella Immunopharma, Inc. - Warrant publicly traded?
Yes, Estrella Immunopharma, Inc. - Warrant is publicly traded.
What exchange does Estrella Immunopharma, Inc. - Warrant trade on?
Estrella Immunopharma, Inc. - Warrant trades on the Nasdaq Stock Market
What is the ticker symbol for Estrella Immunopharma, Inc. - Warrant?
The ticker symbol for Estrella Immunopharma, Inc. - Warrant is ESLAW on the Nasdaq Stock Market
What is the current price of Estrella Immunopharma, Inc. - Warrant?
The current price of Estrella Immunopharma, Inc. - Warrant is 0.1050
When was Estrella Immunopharma, Inc. - Warrant last traded?
The last trade of Estrella Immunopharma, Inc. - Warrant was at 05/28/26 11:10 AM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.

Never miss important news. Subscribe to our newsletter.
Register for free

Information

Copyright 2024. BUSINESS INSURANCE HOLDINGS